{
    "type": "ETF",
    "ucits": true,
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The iShares iBonds Dec 2026 Term $ Corp USD ETF is a physically replicated, UCITS-compliant fund tracking a Bloomberg MSCI USD Corporate ESG Screened Index. It uses physical replication (sampling) to track its index, with no evidence of leverage, inverse strategies, or synthetic replication. The fund's primary risks are credit risk, interest rate risk, and liquidity risk, which are typical for fixed-income ETFs. The KIID and factsheet do not mention derivatives or swaps beyond standard securities lending for cost efficiency. The fund's risk indicator is moderate (3/7), and there are no warnings about complexity or suitability restrictions. The ESG screening and term structure do not introduce additional complexity beyond standard fixed-income risks.",
    "confidence": 95,
    "risk_level": "moderate",
    "counter_argument": "Some might argue that the ESG screening or the term structure (maturity in 2026) could introduce complexity. However, these are standard features of many fixed-income ETFs and do not materially alter the fund's straightforward replication strategy or risk profile. The absence of derivatives, leverage, or synthetic replication confirms its non-complex classification under MiFID II."
}